Concepts (265)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calcium Channels, T-Type | 10 | 2019 | 29 | 3.540 |
Why?
|
| Ethanol | 11 | 2021 | 185 | 2.790 |
Why?
|
| Geniculate Bodies | 19 | 2006 | 21 | 2.530 |
Why?
|
| Thalamus | 8 | 2010 | 39 | 2.190 |
Why?
|
| Neurons | 14 | 2017 | 394 | 2.080 |
Why?
|
| Neural Pathways | 9 | 2018 | 97 | 1.820 |
Why?
|
| Receptors, Metabotropic Glutamate | 7 | 2013 | 23 | 1.610 |
Why?
|
| Magnetoencephalography | 5 | 2021 | 13 | 1.580 |
Why?
|
| Ethosuximide | 3 | 2015 | 3 | 1.470 |
Why?
|
| Calcium Channel Blockers | 4 | 2019 | 49 | 1.430 |
Why?
|
| CA1 Region, Hippocampal | 2 | 2019 | 26 | 1.350 |
Why?
|
| Animals | 46 | 2021 | 7297 | 1.320 |
Why?
|
| Seizures | 3 | 2018 | 61 | 1.310 |
Why?
|
| Nerve Net | 4 | 2021 | 115 | 1.170 |
Why?
|
| Cerebral Cortex | 5 | 2012 | 141 | 1.170 |
Why?
|
| Alcohol Withdrawal Seizures | 2 | 2018 | 2 | 1.170 |
Why?
|
| Substance Withdrawal Syndrome | 3 | 2021 | 53 | 1.140 |
Why?
|
| Central Nervous System Depressants | 6 | 2021 | 63 | 1.120 |
Why?
|
| Brain | 5 | 2021 | 930 | 1.100 |
Why?
|
| Electroencephalography | 4 | 2017 | 71 | 1.060 |
Why?
|
| Alcoholism | 4 | 2021 | 95 | 1.040 |
Why?
|
| Nitric Oxide | 7 | 2006 | 116 | 1.000 |
Why?
|
| Mice | 14 | 2019 | 2368 | 0.960 |
Why?
|
| Brain Mapping | 5 | 2018 | 182 | 0.950 |
Why?
|
| Nitric Oxide Synthase | 6 | 2009 | 36 | 0.910 |
Why?
|
| Pentylenetetrazole | 3 | 2019 | 3 | 0.880 |
Why?
|
| Action Potentials | 6 | 2019 | 174 | 0.860 |
Why?
|
| Status Epilepticus | 2 | 2013 | 22 | 0.810 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2018 | 43 | 0.730 |
Why?
|
| Pyramidal Cells | 1 | 2019 | 15 | 0.720 |
Why?
|
| Alcohol-Induced Disorders, Nervous System | 2 | 2012 | 8 | 0.710 |
Why?
|
| Glutamic Acid | 3 | 2012 | 46 | 0.700 |
Why?
|
| Visual Pathways | 6 | 2002 | 29 | 0.690 |
Why?
|
| Synapses | 6 | 2009 | 85 | 0.680 |
Why?
|
| Benzamides | 1 | 2018 | 54 | 0.650 |
Why?
|
| Piperidines | 1 | 2018 | 125 | 0.620 |
Why?
|
| Feedback | 3 | 2006 | 33 | 0.590 |
Why?
|
| Rest | 1 | 2017 | 49 | 0.590 |
Why?
|
| Brain Concussion | 1 | 2017 | 60 | 0.570 |
Why?
|
| Ferrets | 6 | 2006 | 19 | 0.570 |
Why?
|
| Optical Fibers | 2 | 2014 | 4 | 0.540 |
Why?
|
| Male | 20 | 2019 | 17807 | 0.520 |
Why?
|
| Intralaminar Thalamic Nuclei | 3 | 2005 | 3 | 0.510 |
Why?
|
| Wakefulness | 1 | 2014 | 22 | 0.480 |
Why?
|
| Movement | 1 | 2014 | 41 | 0.480 |
Why?
|
| Pilocarpine | 1 | 2013 | 5 | 0.480 |
Why?
|
| Muscarinic Agonists | 1 | 2013 | 7 | 0.480 |
Why?
|
| Electromyography | 1 | 2013 | 58 | 0.470 |
Why?
|
| Protein Kinase C | 1 | 2013 | 37 | 0.450 |
Why?
|
| Sleep Stages | 1 | 2012 | 6 | 0.450 |
Why?
|
| Channelopathies | 2 | 2010 | 3 | 0.450 |
Why?
|
| Neuronal Plasticity | 2 | 2010 | 81 | 0.430 |
Why?
|
| Brain Stem | 3 | 2009 | 18 | 0.430 |
Why?
|
| Receptors, Serotonin | 1 | 2012 | 6 | 0.420 |
Why?
|
| Mice, Inbred DBA | 3 | 2018 | 36 | 0.420 |
Why?
|
| Anticonvulsants | 4 | 2019 | 63 | 0.410 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 863 | 0.410 |
Why?
|
| Gene Expression | 3 | 2010 | 332 | 0.410 |
Why?
|
| Mice, Inbred C57BL | 5 | 2013 | 711 | 0.410 |
Why?
|
| Biological Clocks | 1 | 2010 | 4 | 0.390 |
Why?
|
| Alcohol Withdrawal Delirium | 1 | 2010 | 3 | 0.390 |
Why?
|
| Ion Channels | 1 | 2010 | 24 | 0.370 |
Why?
|
| Luminescent Proteins | 2 | 2021 | 24 | 0.370 |
Why?
|
| Stress, Psychological | 1 | 2012 | 208 | 0.360 |
Why?
|
| Visual Cortex | 3 | 2005 | 33 | 0.360 |
Why?
|
| Epilepsy | 1 | 2010 | 59 | 0.350 |
Why?
|
| Electric Stimulation | 7 | 2009 | 102 | 0.350 |
Why?
|
| Models, Neurological | 3 | 2021 | 115 | 0.350 |
Why?
|
| Bacterial Proteins | 2 | 2021 | 77 | 0.350 |
Why?
|
| Cats | 12 | 2003 | 105 | 0.350 |
Why?
|
| Mice, Transgenic | 2 | 2019 | 249 | 0.320 |
Why?
|
| Animals, Newborn | 7 | 2006 | 111 | 0.290 |
Why?
|
| Synaptic Transmission | 5 | 2006 | 113 | 0.290 |
Why?
|
| Epilepsy, Absence | 1 | 2006 | 1 | 0.290 |
Why?
|
| Patch-Clamp Techniques | 6 | 2009 | 76 | 0.290 |
Why?
|
| Circadian Rhythm | 1 | 2006 | 43 | 0.280 |
Why?
|
| Excitatory Postsynaptic Potentials | 4 | 2006 | 33 | 0.280 |
Why?
|
| Glycine | 1 | 2005 | 25 | 0.260 |
Why?
|
| Neural Inhibition | 1 | 2005 | 27 | 0.260 |
Why?
|
| Presynaptic Terminals | 1 | 2005 | 36 | 0.250 |
Why?
|
| Amino Acids | 3 | 2013 | 41 | 0.250 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2021 | 33 | 0.250 |
Why?
|
| Evoked Potentials | 2 | 2021 | 16 | 0.240 |
Why?
|
| Immunohistochemistry | 5 | 2009 | 519 | 0.240 |
Why?
|
| Penicillamine | 2 | 2006 | 2 | 0.240 |
Why?
|
| Random Allocation | 2 | 2014 | 213 | 0.230 |
Why?
|
| Gene Expression Regulation | 1 | 2006 | 481 | 0.230 |
Why?
|
| Photic Stimulation | 5 | 1997 | 155 | 0.230 |
Why?
|
| Sleep | 1 | 2003 | 86 | 0.220 |
Why?
|
| Neurofilament Proteins | 2 | 2000 | 11 | 0.220 |
Why?
|
| Nitrergic Neurons | 1 | 2002 | 1 | 0.220 |
Why?
|
| Body Patterning | 1 | 2002 | 5 | 0.210 |
Why?
|
| Microscopy, Confocal | 2 | 2021 | 62 | 0.210 |
Why?
|
| gamma-Aminobutyric Acid | 6 | 2003 | 74 | 0.210 |
Why?
|
| Calcium | 4 | 2019 | 296 | 0.210 |
Why?
|
| Drug Interactions | 3 | 2006 | 80 | 0.210 |
Why?
|
| Bicuculline | 3 | 1993 | 10 | 0.210 |
Why?
|
| Herpesvirus 1, Suid | 1 | 2001 | 2 | 0.210 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 641 | 0.200 |
Why?
|
| Neurotransmitter Agents | 2 | 2000 | 26 | 0.200 |
Why?
|
| Female | 7 | 2021 | 18164 | 0.190 |
Why?
|
| Cell Differentiation | 2 | 2003 | 436 | 0.190 |
Why?
|
| Interneurons | 6 | 2003 | 23 | 0.180 |
Why?
|
| Convulsants | 1 | 2019 | 2 | 0.180 |
Why?
|
| Biomedical Research | 1 | 2021 | 153 | 0.180 |
Why?
|
| Tupaiidae | 2 | 1989 | 2 | 0.180 |
Why?
|
| Magnetic Field Therapy | 1 | 2019 | 17 | 0.170 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 60 | 0.170 |
Why?
|
| Retina | 2 | 1996 | 50 | 0.170 |
Why?
|
| Vision, Monocular | 1 | 1998 | 1 | 0.170 |
Why?
|
| Sensory Deprivation | 1 | 1998 | 15 | 0.170 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 980 | 0.170 |
Why?
|
| Hospitalization | 1 | 2021 | 417 | 0.170 |
Why?
|
| Nitroso Compounds | 1 | 1998 | 2 | 0.160 |
Why?
|
| Light | 1 | 1998 | 25 | 0.160 |
Why?
|
| Membranes, Artificial | 1 | 1998 | 7 | 0.160 |
Why?
|
| Microscopy, Electron | 4 | 2003 | 25 | 0.160 |
Why?
|
| Parvalbumins | 1 | 2017 | 6 | 0.160 |
Why?
|
| Glass | 2 | 1998 | 2 | 0.160 |
Why?
|
| Electromagnetic Fields | 1 | 2018 | 26 | 0.160 |
Why?
|
| Glutathione | 1 | 1998 | 37 | 0.160 |
Why?
|
| Nitric Oxide Donors | 3 | 2006 | 7 | 0.160 |
Why?
|
| Dendrites | 4 | 2003 | 15 | 0.160 |
Why?
|
| Vasodilator Agents | 1 | 1998 | 54 | 0.160 |
Why?
|
| Macaca mulatta | 3 | 2012 | 322 | 0.160 |
Why?
|
| Iontophoresis | 2 | 1996 | 5 | 0.160 |
Why?
|
| Chronic Disease | 2 | 2012 | 369 | 0.160 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 162 | 0.150 |
Why?
|
| Brain Injuries | 1 | 2018 | 94 | 0.150 |
Why?
|
| Membrane Potentials | 3 | 2006 | 80 | 0.150 |
Why?
|
| Equipment Design | 2 | 2014 | 167 | 0.150 |
Why?
|
| Humans | 9 | 2021 | 29093 | 0.140 |
Why?
|
| Contrast Media | 1 | 2017 | 123 | 0.140 |
Why?
|
| Rats | 4 | 2006 | 1604 | 0.140 |
Why?
|
| Xanthenes | 2 | 2006 | 4 | 0.140 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2006 | 26 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2006 | 248 | 0.140 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2006 | 76 | 0.140 |
Why?
|
| Evoked Potentials, Visual | 2 | 2014 | 4 | 0.130 |
Why?
|
| Macaca fascicularis | 2 | 2006 | 389 | 0.130 |
Why?
|
| Photolysis | 3 | 1999 | 4 | 0.130 |
Why?
|
| Alcohol Drinking | 1 | 2017 | 244 | 0.120 |
Why?
|
| Biophysics | 1 | 2014 | 9 | 0.120 |
Why?
|
| RNA, Messenger | 2 | 2006 | 514 | 0.120 |
Why?
|
| Mortality | 1 | 2015 | 109 | 0.120 |
Why?
|
| Electrodes, Implanted | 1 | 2014 | 41 | 0.120 |
Why?
|
| Tungsten | 1 | 1993 | 2 | 0.120 |
Why?
|
| Electrodes | 1 | 1993 | 16 | 0.120 |
Why?
|
| Central Nervous System | 1 | 1993 | 29 | 0.120 |
Why?
|
| Acoustic Stimulation | 1 | 2014 | 125 | 0.120 |
Why?
|
| Down-Regulation | 1 | 2013 | 143 | 0.110 |
Why?
|
| Protein Isoforms | 1 | 2013 | 56 | 0.110 |
Why?
|
| Time Factors | 3 | 2018 | 2001 | 0.110 |
Why?
|
| Acute Disease | 1 | 2013 | 239 | 0.110 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2003 | 83 | 0.110 |
Why?
|
| Maternal Deprivation | 1 | 2012 | 3 | 0.110 |
Why?
|
| Pilot Projects | 1 | 2013 | 469 | 0.110 |
Why?
|
| Behavior, Animal | 1 | 2013 | 264 | 0.100 |
Why?
|
| Neoplasms | 1 | 2018 | 610 | 0.100 |
Why?
|
| Adult | 3 | 2018 | 8420 | 0.090 |
Why?
|
| Afferent Pathways | 3 | 2000 | 23 | 0.090 |
Why?
|
| Cell Size | 4 | 2003 | 32 | 0.090 |
Why?
|
| Electrophysiology | 3 | 1996 | 66 | 0.090 |
Why?
|
| Thalamic Nuclei | 2 | 2001 | 3 | 0.090 |
Why?
|
| Olfactory Bulb | 1 | 2009 | 4 | 0.090 |
Why?
|
| Protein Kinase C-alpha | 1 | 2009 | 6 | 0.090 |
Why?
|
| NADPH Dehydrogenase | 1 | 2009 | 1 | 0.090 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2009 | 10 | 0.090 |
Why?
|
| Middle Aged | 3 | 2018 | 10829 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 82 | 0.090 |
Why?
|
| Somatosensory Cortex | 1 | 2009 | 26 | 0.090 |
Why?
|
| Nitroprusside | 2 | 1999 | 5 | 0.090 |
Why?
|
| Pulvinar | 2 | 2003 | 2 | 0.070 |
Why?
|
| Glutamate Decarboxylase | 2 | 2003 | 17 | 0.070 |
Why?
|
| Cyclic GMP | 1 | 2006 | 11 | 0.070 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2006 | 15 | 0.070 |
Why?
|
| N-Methylaspartate | 1 | 2006 | 12 | 0.070 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2006 | 18 | 0.070 |
Why?
|
| Arginine | 1 | 2006 | 17 | 0.070 |
Why?
|
| Triazoles | 1 | 2006 | 14 | 0.070 |
Why?
|
| Blotting, Northern | 1 | 2006 | 26 | 0.070 |
Why?
|
| Guanosine Diphosphate | 1 | 2006 | 2 | 0.070 |
Why?
|
| Thionucleotides | 1 | 2006 | 3 | 0.070 |
Why?
|
| Picrotoxin | 1 | 2006 | 3 | 0.070 |
Why?
|
| Gluconates | 1 | 2006 | 4 | 0.070 |
Why?
|
| Epilepsy, Generalized | 1 | 2006 | 5 | 0.070 |
Why?
|
| Superoxide Dismutase | 1 | 2006 | 47 | 0.070 |
Why?
|
| Organophosphorus Compounds | 1 | 2006 | 35 | 0.070 |
Why?
|
| Receptors, Glutamate | 1 | 2005 | 6 | 0.070 |
Why?
|
| Calcium Signaling | 1 | 2006 | 40 | 0.070 |
Why?
|
| Cell Membrane | 1 | 2006 | 97 | 0.070 |
Why?
|
| Organ Culture Techniques | 1 | 2005 | 38 | 0.070 |
Why?
|
| Axons | 2 | 2003 | 24 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 162 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2006 | 246 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2006 | 281 | 0.070 |
Why?
|
| Reaction Time | 1 | 2005 | 121 | 0.070 |
Why?
|
| Cyclopropanes | 1 | 2005 | 19 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2006 | 454 | 0.070 |
Why?
|
| Acetylcholine | 2 | 2000 | 47 | 0.060 |
Why?
|
| Biological Transport, Active | 1 | 2001 | 9 | 0.050 |
Why?
|
| Needs Assessment | 1 | 2021 | 66 | 0.050 |
Why?
|
| Societies, Medical | 1 | 2021 | 149 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2001 | 263 | 0.050 |
Why?
|
| Critical Care | 1 | 2021 | 114 | 0.050 |
Why?
|
| Xenon | 1 | 1999 | 2 | 0.050 |
Why?
|
| Fiber Optic Technology | 1 | 1999 | 14 | 0.050 |
Why?
|
| Radiometry | 1 | 2019 | 39 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2019 | 77 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 73 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 113 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2001 | 747 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 109 | 0.040 |
Why?
|
| Cytoskeleton | 1 | 1998 | 16 | 0.040 |
Why?
|
| Alkaline Phosphatase | 1 | 1998 | 36 | 0.040 |
Why?
|
| Neoplastic Stem Cells | 1 | 2019 | 90 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2018 | 1218 | 0.040 |
Why?
|
| S-Nitroso-N-Acetylpenicillamine | 1 | 1998 | 1 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 1998 | 56 | 0.040 |
Why?
|
| S-Nitrosoglutathione | 1 | 1998 | 4 | 0.040 |
Why?
|
| Spectrophotometry | 1 | 1998 | 21 | 0.040 |
Why?
|
| Solutions | 1 | 1998 | 26 | 0.040 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1998 | 18 | 0.040 |
Why?
|
| Reference Values | 1 | 1998 | 224 | 0.040 |
Why?
|
| Nerve Endings | 1 | 1996 | 4 | 0.040 |
Why?
|
| Alcoholic Intoxication | 1 | 2017 | 31 | 0.040 |
Why?
|
| Cell Movement | 1 | 2018 | 161 | 0.040 |
Why?
|
| Primates | 1 | 2017 | 100 | 0.040 |
Why?
|
| Military Personnel | 1 | 2018 | 85 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 1996 | 55 | 0.040 |
Why?
|
| Cycloleucine | 1 | 1996 | 1 | 0.040 |
Why?
|
| Calcium Channels | 1 | 1997 | 56 | 0.040 |
Why?
|
| Receptors, AMPA | 1 | 1996 | 14 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 249 | 0.040 |
Why?
|
| Self Administration | 1 | 2017 | 296 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 720 | 0.030 |
Why?
|
| Aging | 1 | 2002 | 881 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2018 | 573 | 0.030 |
Why?
|
| Norepinephrine | 2 | 2009 | 73 | 0.030 |
Why?
|
| ROC Curve | 1 | 1995 | 149 | 0.030 |
Why?
|
| Visual Perception | 1 | 1995 | 112 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 1356 | 0.030 |
Why?
|
| Lateral Thalamic Nuclei | 2 | 2003 | 2 | 0.030 |
Why?
|
| Signal Transduction | 1 | 1996 | 666 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 1993 | 92 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2009 | 242 | 0.030 |
Why?
|
| Visual Fields | 1 | 1992 | 25 | 0.030 |
Why?
|
| Young Adult | 1 | 2018 | 2402 | 0.030 |
Why?
|
| Neurons, Afferent | 1 | 1992 | 54 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2019 | 3099 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2018 | 3111 | 0.020 |
Why?
|
| Sex Attractants | 1 | 2009 | 1 | 0.020 |
Why?
|
| Calcium Channels, R-Type | 1 | 2009 | 1 | 0.020 |
Why?
|
| Calcium Channels, N-Type | 1 | 2009 | 4 | 0.020 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 1 | 2009 | 8 | 0.020 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2009 | 8 | 0.020 |
Why?
|
| Type C Phospholipases | 1 | 2009 | 9 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 2009 | 24 | 0.020 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2009 | 6 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2009 | 63 | 0.020 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2009 | 32 | 0.020 |
Why?
|
| Fingers | 1 | 2009 | 57 | 0.020 |
Why?
|
| Pons | 1 | 2000 | 7 | 0.010 |
Why?
|
| Cholinergic Fibers | 1 | 2000 | 7 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1997 | 12 | 0.010 |
Why?
|